EUxeler helps pharmaceutical companies address European development challenges such as slow patient enrollment, medical affairs, pharmacovigilance

EUxeler team in Europe is exclusively composed of native speakers European MDs based in Germany, France, Belgium and Eastern Europe who share significant experience in clinical development and medical affairs; at EUxeler clients' request, our experts may visit KOLs/Investigators and provide them with the most relevant information on the investigational product being tested; during their site visits, EUxeler physicians also spend a significant amount of time with Study Coordinators verifying that...

EUxeler team in Europe is exclusively composed of native speakers European MDs based in Germany, France, Belgium and Eastern Europe who share significant experience in clinical development and medical affairs; at EUxeler clients' request, our experts may visit KOLs/Investigators and provide them with the most relevant information on the investigational product being tested; during their site visits, EUxeler physicians also spend a significant amount of time with Study Coordinators verifying that enrollment challenges are being addressed as well as discussing ways to accelerate patient participation in the study. High level contacts with lead investigators provide the opportunity to understand the most current medical practices country by country, as well as how the development candidate i